Such signaling heterogeneity will be related to the acknowledged variability of CLL cell response to BCR engagement (3, 28, 29) and our data provide new insight into this phenomenon through identification of 13 KEGG pathways that show change in the kinome signatures between signaler and non-signaler cells. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.